Subsequent Event (Additional Information) (Details) $ in Thousands		3 Months Ended	9 Months Ended
	Oct. 06, 2022 USD ($) Days shares	Mar. 31, 2021 USD ($)	Sep. 30, 2021 USD ($)	Apr. 03, 2023 USD ($)	Sep. 30, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares
Subsequent Event [Line Items]
Common stock, shares issued | shares					32,834,682	32,792,867
Common Stock, Value, Issued					$ 32	$ 32
Pfizer License Agreement
Subsequent Event [Line Items]
Upfront payments		$ 5,000	$ 5,000
Forecast | Pfizer License Agreement
Subsequent Event [Line Items]
Common Stock, Value, Issued				$ 5,000
Subsequent Event | Pfizer License Agreement
Subsequent Event [Line Items]
Upfront payments	$ 8,000
Common stock, shares issued | shares	2,229,654
Common Stock, Value, Issued	$ 5,000
Percentage of share price equal to closing price	115.00%
Number of days common stock issued from effective date | Days	180
Percentage of ownership interest with difference in value of shares	19.50%
Amount of cash payable	$ 5,000